11,850
Participants
Start Date
November 30, 2015
Primary Completion Date
December 31, 2016
Study Completion Date
December 31, 2016
RSV-F Vaccine
Phosphate Buffer Placebo
Research Site US017, Endwell
Research Site US066, Binghamton
Research Site US049, Rochester
Research Site US067, Norfolk
Research Site US063, Winston-Salem
Research Site US078, Cary
Research Site US020, Durham
Research Site US071, Wilmington
Research Site US070, Charleston
Research Site US056, Mt. Pleasant
Research Site US079, Mt. Pleasant
Research Site US013, Stockbridge
Research Site US045, Savannah
Research Site US062, Birmingham
Research Site US061, Mobile
Research Site US029, Nashville
Research Site US074, Bristol
Research Site US077, Knoxville
Research Site US080, Lexington
Research Site US030, Cleveland
Research Site US081, Cincinnati
Research Site US085, Cincinnati
Research Site US024, Marshfield
Research Site US072, Edina
Research Site US050, Dakota Dunes
Research Site US069, Chicago
Research Site US065, Peoria
Research Site US076, St Louis
Research Site US051, Kansas City
Research Site US003, Lenexa
Research Site US052, Newton
Research Site US058, Wichita
Research Site US018, Omaha
Research Site US025, Norfolk
Research Site US068, Metairie
Research Site US039, Metairie
Research Site US053, Oklahoma City
Research Site US010, Dallas
Research Site US083, Fort Worth
Research Site US060, Fort Worth
Research Site US084, San Angelo
Research Site US019, Houston
Research Site US073, Tomball
Research Site US047, Austin
Research Site US012, Boise
Research Site US027, West Jordan
Research Site US082, Salt Lake City
Research Site US075, Salt Lake City
Research Site US008, Salt Lake City
Research Site US054, Phoenix
Research Site US046, Mesa
Research Site US048, Tempe
Research Site US057, Las Vegas
Research Site US064, San Diego
Research Site US005, Anaheim
Research Site US028, Redding
Research Site US026, Seattle
Research Site US055, Methuen
Research Site US059, Newington
Research Site US044, Warwick
Lead Sponsor
Novavax
INDUSTRY